✦ LIBER ✦

Adriamycin and cyclophosphamide versus hydroxyurea in advanced prostatic cancer. A randomized Southwest Oncology Group study

✍ Scribed by Ronald L. Stephens; Clarence Vaughn; Montague Lane; John Costanzi; Robert O'bryan; Stanley P. Balcerzak; Howard Levin; Jess Frank; Charles A. Coltman Jr

Publisher: John Wiley and Sons
Year: 1984
Tongue: English
Weight: 483 KB
Volume: 53
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19840201)53:3<406::aid-cncr2820530307>3.0.co;2-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adriamycin combinations in advanced brea

Adriamycin combinations in advanced breast cancer: A southwest oncology group study

✍ B. L. Tranum; B. McDonald; T. Thigpen; C. Vaughn; H. Wilson; T. Maloney; J. Cost 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 388 KB 👁 1 views

Cyclophosphamide versus cyclophosphamide

Cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil in advanced prostatic cancer: A randomized trial

✍ Hyman B. Muss; Virginia Howard; Frederick Richards Ii; Douglas R. White; Don V. 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 364 KB

Thirty-two evaluable patients with metastatic carcinoma of the prostate were entered into a prospective randomized trial comparing cyclophosphamide (CYC) with a combination of cyclophosphamide, methotrexate, and fluorouracil (CMF). Progressive disease after endocrine manipulation was noted in 97% (3

Cyclophosphamide, methotrexate, and 5-fl

Cyclophosphamide, methotrexate, and 5-fluorouracil in the treatment of metastatic prostate cancer. A southwest oncology group study

✍ Antoinette J. Wozniak; Brent A. Blumenstein; E. David Crawford; Michael Boileau; 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 381 KB 👁 2 views

Phase III trial of cyclophosphamide vers

Phase III trial of cyclophosphamide versus cyclophosphamide, doxorubicin, and methotrexate in hormone-refractory prostatic cancer: A hoosier oncology group study

✍ Scott Saxman; Rafat Ansari; Ray Drasga; Michael Miller; Ben Wheeler; John McClea 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 489 KB 👁 1 views

Adriamycin in combination for the treatm

Adriamycin in combination for the treatment of breast cancer. A southwest oncology group study

✍ Dr. B. Tranum; B. Hoogstraten; A. Kennedy; C. B. Vaughn; B. Samal; T. Thigpen; S 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 431 KB 👁 2 views

Patients with advanced breast cancer who had not previously received chemotherapy were treated on a three-arm prospective study: adriamycin day 1 plus 5-FU on day 1 and 8 (AF), adriamycin day 1 , plus 5-FU day 1 and 8 , and cyclophosphamide day 1 (AFC), and adriamycin day 1 plus 5-FU day 1 and 8 , c

Randomized trial of 5-fluorouracil and m

Randomized trial of 5-fluorouracil and mitomycin C with or without streptozotocin for advanced pancreatic cancer. A Southwest oncology group study

✍ Ronald M. Bukowski; Stanley P. Balcerzak; Robert M. O'Bryan; John D. Bonnet; T. 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 407 KB 👁 1 views